| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Vaxart (NASDAQ:VXRT) reported its Q4 earnings results on Thursday, March 14, 2024 at 04:01 PM.
Here's what investors need to know about the announcement.
Vaxart beat estimated earnings by 14.000000000000002%, reporting an EPS of $-0.12 versus an estimate of $-0.14.
Revenue was up $3.22 million from the same period last year.
Last quarter the company beat on EPS by $0.07 which was followed by a 5.0% increase in the share price the next day.
Here's a look at Vaxart's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.18 | -0.18 | -0.19 | -0.23 |
| EPS Actual | -0.11 | -0.16 | -0.19 | -0.18 |
| Revenue Estimate | 100K | 80K | 800K | 670K |
| Revenue Actual | 2.10M | 1.36M | 675K | 22K |
To track all earnings releases for Vaxart visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: VXRT
